Single use video laryngoscope: a complete buyer's guide for hospitals

What is a single use video laryngoscope?

A single use video laryngoscope is a disposable intubation device that integrates a camera, light source, and blade into a single unit, used once and discarded to eliminate cross-contamination risk during endotracheal intubation. Unlike conventional reusable systems that require decontamination between patients, this class of anaesthesia airway device is designed for immediate deployment with zero reprocessing burden.

For a more technical grounding, video laryngoscopy overview on Wikipedia provides a useful starting point on the history and mechanics of indirect visualisation techniques. The core principle is straightforward: a miniaturised CMOS or CCD sensor at the blade tip transmits a real-time image to an integrated screen or external monitor, giving the clinician a magnified, indirect view of the glottic opening — typically superior to what direct laryngoscopy alone can offer in anatomically challenging airways.

In clinical environments, these devices are commonly referred to as disposable video laryngoscopes or single-use airway devices. They span several form factors: handheld units with a built-in screen, blade-only disposable components that attach to a reusable handle, and fully integrated throwaway assemblies used in high-infection-risk or pre-hospital settings.

Key structural variants

The market broadly divides into three structural categories. Channelled video laryngoscopes include a pre-formed conduit to guide the endotracheal tube directly — useful for severely limited mouth opening. Non-channelled designs, which mirror the Macintosh geometry most anaesthetists already know, use a separate stylet or bougie. A third hybrid category — the "blade-disposable, handle-reusable" model — attempts to balance infection control with capital equipment cost, though it introduces its own reprocessing obligations for the handle.

Why hospitals are adopting them now

The shift toward single-use airway devices has accelerated sharply since 2020. Infection control intubation protocols tightened across NHS trusts following heightened awareness of pathogen transmission via shared equipment. At the same time, portable video laryngoscope designs have become compact and affordable enough for widespread ward-level stocking rather than restriction to theatres. The 2026 trend picture reinforces this: NHS green procurement targets and a growing "mixed-mode" adoption — disposable blade paired with a reusable handle — are reshaping how trusts structure their airway equipment budgets.

Clinical evidence: first-pass success rates and patient outcomes

The evidence base for video-assisted intubation is substantial, and the picture for single-use devices specifically has become clearer in recent years. NICE Medical Technologies Guidance MIB167 synthesised nine studies covering 5,467 intubation episodes, concluding that video laryngoscopy is non-inferior to direct laryngoscopy in routine airways and offers a demonstrably better glottic view in difficult airway management scenarios.

Across the pooled data, first-pass intubation success rates with video laryngoscopes ranged from 85% to 96% in difficult airway cohorts, compared with 68% to 79% for conventional direct laryngoscopy in comparable patient populations. That is not a marginal difference — it is clinically meaningful, particularly in ICU rapid sequence induction where each failed attempt compounds hypoxic risk.

What the research says about disposable vs reusable performance

A frequently asked question is whether the single-use form factor compromises optical quality. The single-use vs reusable video laryngoscope study published in a peer-reviewed anaesthesia journal found no statistically significant difference in first-pass success rates between disposable and reusable video laryngoscope designs when used by experienced operators. Image resolution and field-of-view metrics were comparable across device classes.

That said, one important caveat belongs here. Some systematic reviews have flagged that in critically ill patients with complex physiology — not simply difficult anatomy — the overall serious complication rate with any video laryngoscope may be marginally higher than with direct laryngoscopy, likely due to longer time-to-intubation in operators still on the learning curve. This is not a reason to avoid these devices; it is a reason to invest in structured simulation training alongside procurement.

"Video laryngoscopy improved Cormack-Lehane grade visualisation in the majority of difficult airway cases reviewed, with a clinically meaningful reduction in oesophageal intubation events compared with direct laryngoscopy alone." — NICE MIB167 evidence summary, synthesised from nine prospective studies (n = 5,467)

Infection control outcomes: the overlooked data

Beyond intubation success, the hygienic laryngoscope argument is compelling on epidemiological grounds. Real-world audit data from UK intensive care units has demonstrated residual organic contamination on reusable laryngoscope handles even after standard decontamination — a finding that aligns with earlier published studies identifying bacterial contamination on up to 30% of "cleaned" handles. A truly single-use device eliminates this vector entirely. For trusts managing immunocompromised patient populations or operating under enhanced infection control protocols, this is often the decisive clinical argument.

Cost analysis: single use vs reusable video laryngoscope

The total cost of ownership (TCO) comparison between single-use and reusable intubation laryngoscope systems is more nuanced than the per-unit price suggests — and this is exactly where many NHS procurement decisions go wrong.

Reusable systems carry a higher upfront capital cost: integrated screen handheld units range from approximately £245 to £7,149 per device, while trolley-mounted systems run from £7,589 to £13,003 (figures based on NICE MIB167 market data, adjusted for 2026 pricing trends). Against this, a disposable video laryngoscope blade typically costs £15 to £45 per unit depending on type and supplier volume agreement.

TCO model: a 12-month per-unit calculation

The table illustrates a counter-intuitive finding: at moderate annual usage volumes (roughly 150–250 intubation procedures per device per year), the per-episode cost of a fully disposable video laryngoscope is broadly comparable to — and in some configurations cheaper than — maintaining a reusable system once decontamination labour and repair contracts are properly costed. Of course, trusts with very high-volume centralised theatre programmes may still find the hybrid "blade-disposable, handle-reusable" model delivers the best economics.

NHS Supply Chain framework pricing

Hospitals purchasing through NHS Supply Chain frameworks can access negotiated pricing tiers that materially reduce the per-unit cost of disposable blades and complete assemblies. Trusts should specifically request quotes under the Anaesthesia and Airway Management category and compare lot pricing across the framework's approved suppliers. Aggregating spend across an ICS (Integrated Care System) rather than purchasing trust-by-trust can unlock further volume discounts of 10–20%.

MHRA, UKCA, and NHS compliance requirements

Any single use video laryngoscope sold in Great Britain must carry a UKCA mark (or, under current transitional provisions extending into 2026, a CE mark remains acceptable for devices placed on the market before the deadline). The MHRA governs medical device regulation post-Brexit under the Medical Devices Regulations 2002 (as amended), and video laryngoscopes are classified as Class IIa active medical devices requiring conformity assessment by a UK Approved Body.

What to verify before procurement

Procurement teams should confirm the following compliance markers on any device under evaluation. Check the MHRA device registration number — all devices placed on the Great Britain market must be registered with the MHRA, and the manufacturer's name should appear on the MHRA's public device register. For devices from international manufacturers, verify that a UK Responsible Person has been designated. On labelling, confirm the single-use symbol (the figure-2 loop with a diagonal line) is present on each individual unit, along with the sterile (STERILE) designation if the device is supplied sterile.

The FDA's parallel register provides a useful cross-reference for global device data: FDA cleared laryngoscope devices lists 510(k) clearances, which, while not directly applicable to UK procurement, can help verify a manufacturer's track record and device classification history.

Infection prevention and control alignment

NHS trusts must align endotracheal intubation equipment choices with their local IPC (Infection Prevention and Control) policy, which in turn should reference NHS England's national clean-air and sterile-field guidance. For single-use airway devices, the key compliance point is confirming that the device is not being reprocessed — a practice that voids the manufacturer's sterility claims and potentially invalidates liability cover. IPC leads should be involved in the product evaluation process, not just the clinical and procurement teams.

Blade selection and difficult airway management

Choosing the right blade geometry is arguably the most clinically consequential decision in the procurement process — and yet it is frequently reduced to "one size fits all" in budget discussions. It should not be. Blade selection directly determines whether a clinician can manage a Grade III or Grade IV Cormack-Lehane airway without escalating to a surgical airway.

Blade types and their clinical indications

The Macintosh-geometry blade suits the majority of routine adult intubations and has the advantage of preserving the option for direct laryngoscopy if the video feed fails. Think of it as the default workhorse — familiar geometry, minimal retraining required. The hyperangulated (or angulated) blade offers a much more anteriorly curved profile, providing superior glottic visualisation in anterior airways, Grade III/IV Cormack-Lehane classifications, or patients with limited cervical extension. The trade-off is that a stylet or rigid intubating stylet is almost always required, and the tube delivery technique is substantially different from Macintosh practice.

Why do so many teams overlook this distinction? Partly because device demonstrations focus on screen image quality rather than tube delivery mechanics — the harder half of the skill. Paediatric and neonatal blade variants are a separate category entirely; trusts covering obstetrics, neonatal ICU, or paediatric wards need to stock appropriately sized blades (typically Size 0 or 1 for neonates, Size 2 for older children).

Practical airway grading guide

1. Grade I / II Cormack-Lehane: Macintosh-geometry blade; standard tube placement technique; no stylet required in most cases.
2. Grade III Cormack-Lehane: Consider hyperangulated blade; rigid intubating stylet recommended; confirm tube tip passage under direct screen visualisation.
3. Grade IV Cormack-Lehane: Channelled video laryngoscope preferred; pre-loaded tube in channel; call for surgical airway backup concurrently.
4. Predicted difficult airway (pre-assessed): Awake fibreoptic intubation remains gold standard; video laryngoscope as primary rescue device with hyperangulated blade stocked and ready.
5. Paediatric / neonatal: Size-appropriate blade mandatory; confirm device compatibility with paediatric ETT sizes; separate procurement lot advisable.

Brand comparison: GlideScope, McGrath, ProVu, and more

The UK market for single-use and hybrid video laryngoscope systems is well-populated. Below is a specification comparison of the most commonly evaluated devices in NHS procurement exercises. Data reflects 2026 market information from manufacturer product documentation and published device evaluations.

Selecting between integrated screen and external monitor designs

Integrated screen designs (McGrath MAC, Timesco ProVu) offer the fastest setup — unbox, power on, intubate. There is no cable to connect, no separate monitor to position. In emergency ward or pre-hospital contexts, this speed advantage is significant. External monitor designs (GlideScope Spectrum with a trolley monitor) deliver a larger image and are better suited to teaching environments where a supervising consultant and trainee both need to see the airway simultaneously. Neither design is universally superior; the right answer depends on the deployment context.

Battery life and storage considerations

For fully disposable units with integrated batteries, shelf-life and battery charge retention are legitimate concerns. Most reputable manufacturers guarantee a minimum 45-minute active screen time per unit and a shelf life of 18–24 months from manufacture. Trusts should confirm these specifications at procurement and establish a stock rotation protocol — first in, first out — to prevent expiry waste. Storage temperature ranges (typically 5°C to 40°C) should also be verified against ward storage environments.

2026 procurement checklist for NHS hospitals

A well-structured evaluation process reduces the risk of committing to a device that performs well in a product demo but poorly under real clinical conditions. The following checklist reflects the collective learning from NHS trust procurement audits and clinical equipment committee reviews.

1. Define clinical use cases: Separate requirements for elective theatre, ICU rapid sequence induction, emergency ward, obstetrics, and paediatrics. One device rarely serves all contexts optimally.
2. Verify UKCA / CE marking and MHRA registration: Request documentation before any clinical evaluation commences. Do not accept verbal assurances.
3. Request NHS Supply Chain framework pricing: Compare lot pricing and confirm VAT position (most medical devices are zero-rated).
4. Calculate TCO including decontamination and maintenance: Use the cost model framework in Section 3 above. Include staff time at banded pay rates for decontamination cycles.
5. Conduct a structured clinical evaluation: Minimum 20–30 intubations per device type, covering both routine and simulated difficult airway scenarios, assessed by at least three clinicians.
6. Assess waste stream impact: Consult the trust's sustainability lead. Evaluate whether manufacturers offer any take-back or recycling scheme — increasingly relevant under NHS net-zero commitments.
7. Confirm training and competency pathway: Especially for hyperangulated blades. Confirm simulator availability and whether the manufacturer provides on-site training.
8. Review IPC policy alignment: Obtain sign-off from the trust's IPC lead that the selected device and its handling protocol are compliant with current NHS infection control guidance.

Procurement without clinical evaluation is a false economy. Equally, clinical evaluation without cost modelling produces decisions that cannot survive financial scrutiny. The most resilient procurement cases combine both with documented regulatory compliance — and that combination is what ultimately gets sign-off from a clinical equipment committee.

The single use video laryngoscope market in 2026 is mature enough that no NHS trust needs to accept a compromise device. The specification range, price points, and evidence base now exist to support a genuinely informed choice — provided the evaluation is structured correctly from the outset.

Frequently asked questions